This shift resembles the adaptive metabolic response observed during caloric restriction or fasting, where anabolic pathways are suppressed and catabolic processes are enhanced to maintain energy homeostasis and preserve mitochondrial function under nutrient-limited conditions
Thats why each design resource includes a dual license for commercial use and personal use
When GLP-1 drugs may be appropriate for lipoedema With all of the above said, there are circumstances where GLP-1 drugs may be a reasonable consideration for women with lipoedema: When prediabetes or type 2 diabetes is present and not adequately controlled through nutrition alone When chronic stress and cortisol dysregulation are significantly impairing metabolic function and the ability to lose abdominal weight, despite a well-structured nutrition protocol When these decisions are made collaboratively with a medical team that understands lipoedema and is actively monitoring muscle mass, bone health, nutritional status, and mental health In all cases, a low-inflammatory, nutritionally balanced eating approach remains essential alongside the medication: GLP-1 drugs are not a replacement for good nutrition

Subsequently, at the end of 2018, in coordination with the European Medicines Agency (EMA) and the Federal Institute for Drugs and Medical Devices (BfArM), a red hand letter was issued, explaining the connection between increasing doses of hydrochlorothiazide and the development of non-melanoma skin cancer
It is important to note that semaglutide is not a cure for diabetes, but it can be a valuable tool in managing the condition alongside other measures like diet, exercise, and other medications